Translate page

  • Presentations from the EHA2022 Congress

  • EHA 2022: Mechanisms of disease progression in chronic myeloid leukemia (S. Tiong Ong)

  • EHA 2022: Non-BCR-ABL1 biomarkers of prognosis in CML (Shady Awad)

  • COLT Meeting 2019: CML related topics

  • COLT Meeting 2019: The CML frontier

    Logo World Cancer DayFebruary 2021 - Today is World Cancer Day. I Am and I Will.

    WE ARE a global Foundation with the mission to improve the outcomes of patients with CML globally and WE WILL be working towards a cure for CML.

    "There are currently estimated to be over 800,000 CML patients globally. CML is predicted to become the most prevalent leukaemia by 2040 when there are projected to be over 3 million patients worldwide. A concerted global effort working towards a cure is imperative.
    The iCMLf is uniquely positioned to drive this effort.” 
    (Tim Hughes, iCMLf Chairman)

    Let’s create a future without CML. The time to act is now.

    Learn more about the iCMLf CURE Consortium and how we bring interested parties together on specific projects under the banner of cure.